Policy / Pricing

Biotech leaders pitch Pazdur as next FDA chief

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

pharminent May 14, 2026 (Last updated: May 14, 2026)

BioSpace

In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to lead the agency after the departure of Marty Makary.

Read full story

Related Stories

The next FDA commissioner must be a champion for gene therapies

Stakeholders want Makary’s voucher program paused, call for FDA independence

SCOTUS backs generic firm Hikma in skinny label dispute

You May Have Missed

Lilly and Novo face off at ADA 2026 as others seek to compete in obesity

Medicare Advantage in 2026: Enrollment Update and Key Trends

The next FDA commissioner must be a champion for gene therapies

Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data